MICHAEL CLARK: Open Payments
NPI 1326006834 · BEDFORD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$627 in 25 payments from 14 companies in 2025. Trend: 2023 $1,031 · 2024 $875 · 2025 $627
Food & beverage: $627
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 4 | $93 |
| Inspire Medical Systems, Inc. | 2 | $83 |
| Novartis Pharmaceuticals Corporation | 3 | $73 |
| Abbott Laboratories | 2 | $72 |
| Boston Scientific Corporation | 1 | $58 |
| Novo Nordisk Inc | 2 | $45 |
| Merck Sharp & Dohme LLC | 2 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| Amgen Inc. | 2 | $30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
Products named: INSPIRE, ONPATTRO, APOLLO ESG System, NA, Wegovy, VERQUVO, LEQVIO, Kerendia.
Industry payments across TX — which companies pay providers there.
